Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2026-04-15 @ 3:47 AM
Study NCT ID:
NCT06679634
Status:
RECRUITING
Last Update Posted:
2025-04-03
First Post:
2024-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Retinoblastoma Phase II Expanded Access Clinical Trial
Sponsor:
Targeted Therapy Technologies, LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
3TRB01-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |